In clinical subjects, superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH), glutathione peroxidase (GPx), and GSH reductase (GR) in serum/plasma have been reportedly modulating in early and advanced NAFLD patients [31]. This evidence concerns the gene CAT and metabolic dysfunction-associated steatotic liver disease.